Variant report
Variant | nsv514237 |
---|---|
Chromosome Location | chr4:106710207-106716663 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs185240680 | chr4:106710263-106710264 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs568086631 | chr4:106710270-106710271 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs190185879 | chr4:106710351-106710352 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs558383146 | chr4:106710364-106710365 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs72673812 | chr4:106710454-106710455 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs576828144 | chr4:106710535-106710536 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs539694639 | chr4:106710551-106710552 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs143985967 | chr4:106710552-106710553 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs139922752 | chr4:106710610-106710611 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs542094285 | chr4:106710650-106710651 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs72673813 | chr4:106710653-106710654 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs80281217 | chr4:106710737-106710738 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs541374295 | chr4:106710873-106710874 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs141812721 | chr4:106710884-106710885 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs533463783 | chr4:106710896-106710897 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs373085582 | chr4:106710933-106710934 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs146279236 | chr4:106710952-106710953 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs559974599 | chr4:106710960-106710961 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs531506977 | chr4:106711043-106711044 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs9996545 | chr4:106711068-106711069 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs561480091 | chr4:106711149-106711150 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs548520568 | chr4:106711160-106711161 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs376282148 | chr4:106711163-106711164 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs568322948 | chr4:106711241-106711242 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs181372359 | chr4:106711314-106711315 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs547369275 | chr4:106711364-106711365 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs573380066 | chr4:106711366-106711367 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs374864692 | chr4:106711376-106711377 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs527406707 | chr4:106711380-106711381 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs539501889 | chr4:106711399-106711400 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs112819759 | chr4:106711416-106711417 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs116817670 | chr4:106711424-106711425 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs535616058 | chr4:106711462-106711463 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs555649454 | chr4:106711480-106711481 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs185695461 | chr4:106711545-106711546 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs13116787 | chr4:106711603-106711604 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs541113651 | chr4:106711621-106711622 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs114815407 | chr4:106711649-106711650 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs578054736 | chr4:106711652-106711653 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs543956928 | chr4:106711661-106711662 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs563739579 | chr4:106711684-106711685 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs60822027 | chr4:106711697-106711698 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs531547260 | chr4:106711868-106711869 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs542001178 | chr4:106711906-106711907 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs72673814 | chr4:106711993-106711994 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs190011150 | chr4:106711994-106711995 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs368954826 | chr4:106712048-106712049 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs552005612 | chr4:106712091-106712092 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs180911932 | chr4:106712104-106712105 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs372444596 | chr4:106712129-106712130 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 16573809 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Melanoma | 20688739 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Myelofibrosis | 22110671 | CNVD |
myeloid cancer | 21057493 | CNVD |
Cognitive impairment | 21505072 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Schizophrenia | 23813976 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:106692400-106729400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr4:106694000-106718200 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
3 | chr4:106695200-106757000 | Weak transcription | Primary B cells from cord blood | blood |
4 | chr4:106697200-106725800 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
5 | chr4:106697800-106723200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
6 | chr4:106698000-106725200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
7 | chr4:106698200-106719200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
8 | chr4:106703200-106755600 | Weak transcription | Primary hematopoietic stem cells | blood |
9 | chr4:106705600-106713400 | Weak transcription | HSMM | muscle |
10 | chr4:106710400-106711000 | Weak transcription | Left Ventricle | heart |
11 | chr4:106710600-106710800 | Enhancers | Pancreas | Pancrea |
12 | chr4:106710600-106711000 | Enhancers | H9 Cell Line | embryonic stem cell |
13 | chr4:106714200-106725800 | Weak transcription | H1 Cell Line | embryonic stem cell |